| 产品详情 |
| Edit |   |
|---|
| Product Name | HQL-79 |
|---|
| Description | HQL-79 is a selective inhibitor of hematopoietic PGD synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine.{11338} Subsequent evaluation in models of allergy and asthma demonstrates the HQL-79 is orally available, and inhibits the synthesis of PGD2 (Item No. 12010).{11337} HQL-79 is thus a likely lead compound for the preparation of potent, selective hematopoietic PGD synthase inhibitors. |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | inhibitors prostaglandins synthases PGD2 L-PGDS tetrazoles HQL79 inhibits lipocalin-type |
|---|
| Gene, Accession, CAS # | CAS: 162641-16-9 |
|---|
| Catalog # | 10134-10 |
|---|
| Price | |
|---|
| Order / More Info | HQL-79 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|